Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

West Pharmaceutical Services, Inc. (WST)

Surgical & Medical Instruments & Apparatus

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

530 HERMAN O. WEST DRIVE
EXTON, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/27/1980

Market Cap

21,471,588,184

Shares Outstanding

73,990,000

Weighted SO

73,989,670

Total Employees

N/A

Upcoming Earnings

07/25/2024

Similar Tickers

TFX --.--%

ALC --.--%

RMD --.--%

ICUI --.--%

COO --.--%

HOLX --.--%

HAE --.--%

BDX --.--%

RGEN --.--%

Beta

0.9950

Last Div

0.8000

Range

265.0-415.73

Chg

3.3900

Avg Vol

649366

Mkt Cap

21471588184

Exch

NYSE

Country

US

Phone

610 594 2900

DCF Diff

99.5812

DCF

193.0188

Div Yield

0.0027

P/S

7.4637

EV Multiple

28.0523

P/FV

8.3853

Div Yield %

0.2703

P/E

41.1645

PEG

3.1239

Payout

0.1107

Current Ratio

2.3402

Quick Ratio

1.6787

Cash Ratio

0.7041

DSO

63.6923

DIO

82.7607

Op Cycle

146.4530

DPO

41.7949

CCC

104.6581

Gross Margin

0.3573

Op Margin

0.2057

Pretax Margin

0.2125

Net Margin

0.1825

Eff Tax Rate

0.1672

ROA

0.1504

ROE

0.1908

ROCE

0.2072

NI/EBT

0.8587

EBT/EBIT

1.0330

EBIT/Rev

0.2057

Debt Ratio

0.0651

D/E

0.0881

LT Debt/Cap

0.0275

Total Debt/Cap

0.0810

Int Coverage

82.1944

CF/Debt

3.3145

Equity Multi

1.3542

Rec Turnover

5.7307

Pay Turnover

8.7331

Inv Turnover

4.4103

FA Turnover

1.7595

Asset Turnover

0.8244

OCF/Share

10.3068

FCF/Share

4.8918

Cash/Share

6.1123

OCF/Sales

0.2615

FCF/OCF

0.4746

CF Coverage

3.3145

ST Coverage

4.8825

CapEx Coverage

1.9034

Div&CapEx Cov

1.6595

P/BV

8.3853

P/B

8.3853

P/S

7.4637

P/E

41.1645

P/FCF

60.1277

P/OCF

28.7178

P/CF

28.7178

PEG

3.1239

P/S

7.4637

EV Multiple

28.0523

P/FV

8.3853

DPS

0.8000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 23, 22:19 WST IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 12, 22:21 SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services GlobeNewswire Inc. Jun 12, 22:08 WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit GlobeNewswire Inc. Jun 10, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 03, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire Inc. May 29, 21:57 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST GlobeNewswire Inc. May 26, 20:07 ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST GlobeNewswire Inc. May 17, 17:08 ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST GlobeNewswire Inc. May 15, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 20, 21:10 Casella Waste Systems, Inc. to Host Conference Call on Its Fourth Quarter 2024 Results Benzinga Sep 15, 23:08 Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? Benzinga Jan 17, 15:21 Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion MarketWatch Jan 09, 09:13 Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024 GlobeNewswire Inc. Dec 29, 11:42 New Hampshire Supreme Court Decision Upholds Stage VI Permit Issuance GlobeNewswire Inc. Dec 29, 11:42 New Hampshire Supreme Court Decision Upholds Stage VI Permit Issuance GlobeNewswire Inc. Dec 06, 16:30 Casella Waste Systems, Inc. Announces Diesel Technician Training Program Benzinga Nov 17, 13:01 Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.20 07/31/2024 04/25/2024 07/31/2024 08/07/2024
0.20 04/23/2024 02/20/2024 04/24/2024 05/01/2024
0.20 01/30/2024 12/06/2023 01/31/2024 02/07/2024
0.20 11/07/2023 10/26/2023 11/08/2023 11/15/2023
0.19 07/25/2023 04/27/2023 07/26/2023 08/02/2023
0.19 04/25/2023 03/03/2023 04/26/2023 05/03/2023
0.19 01/24/2023 12/13/2022 01/25/2023 02/01/2023
0.19 11/08/2022 10/27/2022 11/09/2022 11/16/2022
0.18 07/19/2022 04/28/2022 07/20/2022 08/03/2022
0.18 04/19/2022 02/23/2022 04/20/2022 05/04/2022
0.18 01/18/2022 01/05/2022 01/19/2022 02/02/2022
0.18 11/09/2021 10/28/2021 11/10/2021 11/17/2021
0.17 07/20/2021 05/05/2021 07/21/2021 08/04/2021
0.17 04/20/2021 02/24/2021 04/21/2021 05/05/2021
0.17 01/19/2021 12/09/2020 01/20/2021 02/03/2021
0.17 11/09/2020 10/28/2020 11/11/2020 11/18/2020
0.16 07/28/2020 07/15/2020 07/29/2020 08/05/2020
0.16 04/21/2020 02/25/2020 04/22/2020 05/06/2020
0.16 01/21/2020 12/13/2019 01/22/2020 02/05/2020
0.16 10/22/2019 07/25/2019 10/23/2019 11/06/2019
0.15 07/23/2019 05/08/2019 07/24/2019 08/07/2019
0.15 04/16/2019 02/21/2019 04/17/2019 05/01/2019
0.15 01/22/2019 12/18/2018 01/23/2019 02/06/2019
0.15 10/23/2018 05/03/2018 10/24/2018 11/07/2018
0.14 07/17/2018 05/03/2018 07/18/2018 08/01/2018
0.14 04/17/2018 02/15/2018 04/18/2018 05/02/2018
0.14 01/17/2018 12/22/2017 01/18/2018 02/01/2018
0.14 10/17/2017 07/20/2017 10/18/2017 11/01/2017
0.13 07/17/2017 05/16/2017 07/19/2017 08/02/2017
0.13 04/17/2017 02/16/2017 04/19/2017 05/03/2017
0.13 01/13/2017 12/14/2016 01/18/2017 02/01/2017
0.13 10/17/2016 09/12/2016 10/19/2016 11/02/2016
0.12 07/18/2016 07/06/2016 07/20/2016 08/03/2016
0.12 04/18/2016 03/04/2016 04/20/2016 05/04/2016
0.12 01/15/2016 12/17/2015 01/20/2016 02/03/2016
0.12 10/19/2015 09/18/2015 10/21/2015 11/04/2015
0.11 07/20/2015 07/02/2015 07/22/2015 08/05/2015
0.11 04/20/2015 02/20/2015 04/22/2015 05/06/2015
0.11 01/16/2015 12/22/2014 01/21/2015 02/04/2015
0.11 10/20/2014 07/17/2014 10/22/2014 11/05/2014
0.10 07/21/2014 05/08/2014 07/23/2014 08/06/2014
0.10 04/21/2014 02/20/2014 04/23/2014 05/07/2014
0.10 01/17/2014 12/20/2013 01/22/2014 02/05/2014
0.10 10/21/2013 08/02/2013 10/23/2013 11/06/2013
0.19 07/22/2013 05/10/2013 07/24/2013 08/07/2013
0.19 04/15/2013 03/15/2013 04/17/2013 05/01/2013
0.19 01/18/2013 12/27/2012 01/23/2013 02/06/2013
0.19 10/22/2012 10/01/2012 10/24/2012 11/07/2012
0.18 07/16/2012 05/21/2012 07/18/2012 08/01/2012
0.18 04/16/2012 03/01/2012 04/18/2012 05/02/2012
0.18 01/13/2012 01/10/2012 01/18/2012 02/01/2012
0.18 10/17/2011 10/10/2011 10/19/2011 11/02/2011
0.17 07/18/2011 05/06/2011 07/20/2011 08/03/2011
0.17 04/18/2011 02/24/2011 04/20/2011 05/04/2011
0.17 01/14/2011 12/16/2010 01/19/2011 02/02/2011
0.17 10/18/2010 10/04/2010 10/20/2010 11/03/2010
0.16 07/19/2010 05/07/2010 07/21/2010 08/04/2010
0.16 04/19/2010 02/23/2010 04/21/2010 05/05/2010
0.16 01/15/2010 12/16/2009 01/20/2010 02/03/2010
0.16 10/19/2009 10/02/2009 10/21/2009 11/04/2009
0.15 07/20/2009 05/06/2009 07/22/2009 08/05/2009
0.15 04/20/2009 02/25/2009 04/22/2009 05/06/2009
0.15 01/16/2009 12/18/2008 01/21/2009 02/04/2009
0.15 10/20/2008 09/22/2008 10/22/2008 11/05/2008
0.14 07/21/2008 05/07/2008 07/23/2008 08/06/2008
0.14 04/21/2008 02/27/2008 04/23/2008 05/07/2008
0.14 01/18/2008 12/14/2007 01/23/2008 02/06/2008
0.14 10/22/2007 09/20/2007 10/24/2007 11/07/2007
0.13 07/16/2007 07/10/2007 07/18/2007 08/01/2007
0.13 04/16/2007 03/14/2007 04/18/2007 05/02/2007
0.13 01/22/2007 12/12/2006 01/24/2007 02/07/2007
0.13 10/16/2006 09/20/2006 10/18/2006 11/01/2006
0.12 07/17/2006 06/27/2006 07/19/2006 08/02/2006
0.12 04/17/2006 02/28/2006 04/19/2006 05/03/2006
0.12 01/13/2006 12/14/2005 01/18/2006 02/01/2006
0.12 10/17/2005 08/16/2005 10/19/2005 11/02/2005
0.11 07/18/2005 06/28/2005 07/20/2005 08/03/2005
0.11 04/18/2005 03/07/2005 04/20/2005 05/04/2005
0.11 01/14/2005 12/14/2004 01/19/2005 02/02/2005
0.11 10/18/2004 08/24/2004 10/20/2004 11/03/2004
0.21 07/19/2004 06/29/2004 07/21/2004 08/04/2004
0.21 04/19/2004 03/25/2004 04/21/2004 05/05/2004
0.21 01/16/2004 10/28/2003 01/21/2004 02/04/2004
0.21 10/20/2003 08/12/2003 10/22/2003 11/05/2003
0.20 07/21/2003 06/17/2003 07/23/2003 08/06/2003
0.20 04/21/2003 03/24/2003 04/23/2003 05/07/2003
0.20 01/17/2003 10/28/2002 01/22/2003 02/05/2003
0.20 10/21/2002 07/30/2002 10/23/2002 11/06/2002
0.19 07/22/2002 06/18/2002 07/24/2002 08/07/2002
0.19 04/15/2002 03/11/2002 04/17/2002 05/01/2002
0.19 01/18/2002 12/04/2001 01/23/2002 02/06/2002
0.19 10/22/2001 08/06/2001 10/24/2001 11/07/2001
0.18 07/16/2001 06/19/2001 07/18/2001 08/01/2001
0.18 04/16/2001 03/12/2001 04/18/2001 05/02/2001
0.18 01/22/2001 12/12/2000 01/24/2001 02/07/2001
0.18 10/16/2000 08/01/2000 10/18/2000 11/01/2000
0.17 07/17/2000 06/20/2000 07/19/2000 08/02/2000
0.17 04/17/2000 03/27/2000 04/19/2000 05/03/2000
0.17 01/14/2000 12/14/1999 01/19/2000 02/02/2000
0.17 10/18/1999 08/03/1999 10/20/1999 11/03/1999
0.16 07/19/1999 04/27/1999 07/21/1999 08/04/1999
0.16 04/19/1999 03/08/1999 04/21/1999 05/05/1999
0.16 01/15/1999 12/15/1998 01/20/1999 02/03/1999
0.16 10/19/1998 08/11/1998 10/21/1998 11/04/1998
0.15 07/20/1998 07/02/1998 07/22/1998 08/05/1998
0.15 04/20/1998 03/10/1998 04/22/1998 05/06/1998
0.15 01/16/1998 12/17/1997 01/21/1998 02/04/1998
0.15 10/20/1997 08/05/1997 10/22/1997 11/05/1997
0.14 07/21/1997 04/30/1997 07/23/1997 08/06/1997
0.14 04/21/1997 03/07/1997 04/23/1997 05/07/1997
0.14 01/17/1997 12/17/1996 01/22/1997 02/05/1997
0.14 10/21/1996 08/06/1996 10/23/1996 11/06/1996
0.13 07/22/1996 05/06/1996 07/24/1996 08/07/1996
0.13 04/15/1996 03/11/1996 04/17/1996 05/01/1996
0.13 01/22/1996 12/13/1995 01/24/1996 02/07/1996
0.13 10/16/1995 08/29/1995 10/18/1995 11/01/1995
0.12 07/17/1995 05/02/1995 07/19/1995 08/02/1995
0.12 04/12/1995 03/07/1995 04/19/1995 05/03/1995
0.12 01/11/1995 11/30/-0001 01/18/1995 02/01/1995
0.12 10/13/1994 11/30/-0001 10/19/1994 11/02/1994
0.11 07/14/1994 11/30/-0001 07/20/1994 08/03/1994
0.11 04/14/1994 11/30/-0001 04/20/1994 05/04/1994
0.11 01/12/1994 11/30/-0001 01/19/1994 02/02/1994
0.11 10/14/1993 11/30/-0001 10/20/1993 11/03/1993
0.10 07/15/1993 11/30/-0001 07/21/1993 08/04/1993
0.10 04/15/1993 11/30/-0001 04/21/1993 05/05/1993
0.10 01/13/1993 11/30/-0001 01/20/1993 02/03/1993
0.10 10/15/1992 11/30/-0001 10/21/1992 11/04/1992
0.10 07/16/1992 11/30/-0001 07/22/1992 08/05/1992
0.10 04/15/1992 11/30/-0001 04/22/1992 05/06/1992
0.10 01/15/1992 11/30/-0001 01/22/1992 02/05/1992
0.10 10/17/1991 11/30/-0001 10/23/1991 11/06/1991
0.10 07/18/1991 11/30/-0001 07/24/1991 08/07/1991
0.10 04/11/1991 11/30/-0001 04/17/1991 05/01/1991
0.10 01/16/1991 11/30/-0001 01/23/1991 02/06/1991
0.10 10/18/1990 08/02/1990 10/24/1990 11/07/1990
0.10 07/12/1990 05/04/1990 07/18/1990 08/01/1990
0.10 04/11/1990 03/14/1990 04/18/1990 05/02/1990
0.10 01/18/1990 12/19/1989 01/24/1990 02/07/1990
0.08 10/12/1989 08/01/1989 10/18/1989 11/01/1989
0.08 07/13/1989 05/02/1989 07/19/1989 08/02/1989
0.08 04/13/1989 03/07/1989 04/19/1989 05/03/1989
0.08 01/11/1989 01/05/1989 01/18/1989 02/01/1989
0.08 10/13/1988 08/08/1988 10/19/1988 11/02/1988
0.08 07/14/1988 05/10/1988 07/20/1988 08/03/1988
0.07 04/14/1988 03/10/1988 04/20/1988 05/04/1988
0.07 01/13/1988 11/09/1987 01/20/1988 02/03/1988
0.07 10/15/1987 08/07/1987 10/21/1987 11/04/1987
0.07 07/15/1987 05/01/1987 07/21/1987 08/05/1987
0.13 04/14/1987 03/24/1987 04/21/1987 05/05/1987
0.13 01/26/1987 01/16/1987 01/30/1987 02/06/1987